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Abstract
A 27 year old female presented with two months
history of continuous vaginal bleeding. On evaluation, she
was diagnosed as a case of vaginal clear cell
adenocarcinoma (VCCA) along with associated Müllerian
duct anomalies including didelphys uterus with double
vagina; left sided renal agenesis and situs inversus.
Although VCCA is strongly linked to in-utero exposure
with Diethyl stillboestrol (DES), this patient had no known
history regarding such exposure. Also, only a few cases
have been described in the literature in which this tumour
was seen in association with Müllerian duct anomalies and
renal agenesis; in the absence of known DES exposure. 
Introduction
Clear cell adenocarcinoma is an uncommon
malignancy involving vagina which has been strongly
linked to in-utero exposure of the female foetus with
Diethyl stilboestrol (DES).1,2 DES exposure is also
associated with Müllerian duct anomalies including vaginal
adenosis, cervical ectropion and cervicovaginal ridges.3
Primary vaginal clear cell adenocarcinoma unrelated to
DES is a rare finding.1 However, presence of this tumour in
association with Müllerian duct anomalies along with renal
agenesis and situs inversus, in the absence of DES exposure
is even rarer. We present a case of 27-year-old female
presented with continuous bloody vaginal discharge that
was later diagnosed to have vaginal clear cell
adenocarcinoma along with congenital anomalies including
didelphys uterus with double vagina, left sided renal
agenesis and situs inversus. There was no known in-utero
exposure with DES in this patient.
Case Report
A 27-year-old woman, married for 3 months,
presented with continuous bloody vaginal discharge for the
last two months. The patient also had a history of irregular
prolonged menstrual cycle for the last one year.
Initial physical examination showed situs inversus.
Ultrasound showed bicornuate uterus with right horn of
uterus measuring 5.2 X 3.8cm and left horn measuring 5.9
X 3.9cm. Left kidney was found to be absent with
compensatory enlargement of the right kidney.
Haematometra in the body and cervix of the left uterine
horn suggested a vaginal septum on the left side. Vaginal
examination showed no definitive cervix, however, on the
left side, a pin-hole dimple was identified with oozing of
blood stained fluid and cheesy suspicious looking material,
which was sent for histopathology with the clinical
suspicion of malignancy versus retained products of
conception. The specimen received for histopathology was
coded as "Tissue from the pouch below the uterus". It
consisted of multiple light to dark brown, friable and
irregular soft tissue fragments, collectively measuring 12 X
12 X 3cm approximately. No gestational sac, foetal parts or
chorionic villi were grossly identified and representative
sections were submitted for microscopic examination.
Histopathology of this tissue showed fragments of a cellular
neoplastic lesion with extensive haemorrhage and necrosis.
The tumour cells were large and polygonal and were
arranged in sheets, nests and tubules. The cells had
abundant, clear to finely granular cytoplasm and distinct
cellular borders. The nuclei were large, pleomorphic and
had course chromatin and prominent nucleoli. Abundant
cytoplasmic glycogen was seen on PAS ± diastase special
stains. Scattered mitotic figures were also seen. There were
areas showing prominent hobnailing of the tumour cells
(Figure-1). On immunohistochemistry, tumour cells showed
positivity for cytokeratin AE1/AE3 and negativity for
vimentin, CD10, placental alkaline phosphatase (PLAP)
and CD117 (c-kit). No normal tissue was identified to
determine the possible origin of this neoplasm. Based on the
morphological and immunohistochemical features, a
diagnosis of clear cell adenocarcinoma was made and
clinical correlation was recommended for determining the
site of biopsy as these tumours can arise from endometrium,
cervix or vagina. 
With these differential diagnosis, a laparotomy and
possible Wertheim's hysterectomy was scheduled.
Peroperatively, two uteri were identified opening in a single
dilated pouch like structure which was later found out to be
the left vagina as this patient had didelphys uterus with
double vagina. Both adnexae and bowel loops were normal
568 J Pak Med Assoc
Case Report
Vaginal clear cell adenocarcinoma with associated Müllerian duct
anomalies, renal agenesis and situs inversus: Report of a case with no
known in-utero exposure with Diethyl stilboestrol
Zeeshan-ud-din, Aamir Ahsan
Section of Histopathology, Department of Pathology & Microbiology, The Aga Khan University Hospital, Karachi.
grossly. Pelvic lymph nodes were enlarged. Wertheim's
hysterectomy with partial vaginectomy and pelvic lymph
node dissection was carried out and specimen was sent for
histopathology. Both the ovaries were conserved. 
Grossly the specimen consisted of two uteri, two
cervices and two vaginas along with bilateral external iliac
and obturator lymph nodes. Right sided uterus, cervix and
vagina measured 9.5 X 4 X 2.5cm in the greatest
dimensions. Left sided uterus, cervix and vagina measured
10 X 3.5 X 2.5cm in the greatest dimensions. Grossly the
tumour was involving the upper left vagina, and was grayish
brown, fungating in appearance and was reaching up to the
inferior resection margin (Figure-2). The tumour measured
4.4 X 4cm in the greatest dimensions. The left vagina had a
blind lower end with a pin-hole opening in the septum
through which it was communicating with the grossly
unremarkable vagina on the right side. Apart from a small
myometrial nodule in the right uterus, both of the uteri,
cervices and right vagina were grossly unremarkable.
Tumour of similar histology as described earlier in
the biopsy specimen was seen involving the left vaginal
mucosa and underlying fibromuscular tissue however it was
not extending to the serosa. The inferior resection margin
was microscopically positive for the tumour as well.
Sections from both of the uteri, cervices, right vagina and
both fallopian tubes were tumour free. Out of nine pelvic
lymph nodes sent for histopathology, only one was involved
by metastatic clear cell adenocarcinoma. 
Discussion
Clear cell adenocarcinoma most commonly involves
ovary, cervix, and urinary tract including kidney.1 Vaginal
clear cell adenocarcinomas (VCCA) account for only 5-
10% of all vaginal cancers, the vast majority being
squamous cell carcinoma.2 VCCA most commonly involves
the anterior wall of the upper third of vagina, corresponding
to the most frequent site of adenosis, with which it has been
associated. The tumour size is variable ranging from
microscopic to large. Most of the larger tumours are
polypoidal or nodular in appearance and are mostly
superficially invasive. Microscopically, the tumour is
characterized by solid sheets of clear cells, the clear
appearance of cytoplasm being caused by dissolution of
glycogen during the processing of the specimen. A second
pattern is characterized by tubules and cysts lined by
hobnail cells, and by flat cells, or by cells that resemble
Müllerian type epithelium to varying degrees.3 In our case,
tumour was fungating in gross appearance and was
involving the upper part of vagina. The histopathological
examination revealed a classical pattern of VCCA including
clear cells showing hobnailing.
VCCA is most commonly related to in-utero
diethylstilbestrol (DES) exposure.1,2,4,5 DES is a synthetic
estrogen which was prescribed for threatened or repeated
abortions from 1940's to early 1970's.6 The absolute risk of
clear cell adenocarcinoma of vagina or cervix in the
daughters of DES-exposed mothers is 1 in 1000.6 Primary
VCCA is a rare entity except for this well-known
association.1 There are multiple reported cases of VCCA in
which there was no in-utero exposure to DES.1,7,8 Apart
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Figure-1: Vaginal clear cell adenocarcinoma showing tubules lined by polygonal
clear cells with prominent hobnailing (arrow).
Figure-2: Didelphys uterus with double vagina showing clear cell adenocarcinoma
involving left vagina (arrow).
from clear cell adenocarcinoma, a number of non-neoplastic
changes have also been identified in the genital tract of
DES-exposed women, such as adenosis, cervical ectropion,
cervicovaginal ridges, and structural anomalies of uterine
corpus and fallopian tube.3 In our case, although there was
no known history of in-utero DES exposure, still Müllerian
duct anomalies such as didelphys uterus with double vagina,
were identified along with left sided renal agenesis and situs
inversus. The association between Müllerian duct anomalies
and renal agenesis has been well documented. Müllerian
duct anomalies occur in 1-15% of women associated with
renal anomalies especially agenesis or ectopia.9 However,
like our cases only a few cases have been described in the
literature in which a coexistence of such anomalies with
VCCA in the absence of any known DES exposure was
seen. One such case has been reported by Satou and
Takasu8 in a 38-year-old female who had not been exposed
to DES in-utero. Their patient had a congenital
malformation of the genital tract; the uterus was bicornuate
and the urinary tract exhibited unilateral renal agenesis.8 In
another study, Nordqvist et al7 reviewed twenty one cases
of vaginal and cervical clear cell adenocarcinoma, out of
which thirteen had no prior DES exposure. In their study,
two of the non-DES related cases had coexisting congenital
malformations with double uterus and vagina and unilateral
renal agenesis as seen in our case.7 Ott et al10 reported a
case of clear cell adenocarcinoma of the upper vagina in a
17-year-old DES non-exposed German girl, who had a
history of hypoplasia of the left kidney with an ectopic
termination of the ureter in the upper vagina. They have
suggested that congenital anomaly of the ureter interfering
with the development and the differentiation of the distal
Müllerian duct and its epithelium might have provided a
similar histological basis for carcinogenesis in their patient
to that in those exposed to DES.10
Conclusion
Based on the cases described previously and the one
reported here, it is presumed that a separate group of VCCA
exists which is associated with Müllerian duct anomalies in
the absence of DES exposure. Also, renal agenesis may
directly or indirectly predispose to VCCA. Whether these
associations are causal or incidental remains to be
determined.
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